Kestra Medical Technologies, Ltd. Net Income (Loss) Attributable to Noncontrolling Interest
Kestra Medical Technologies, Ltd. (KMTS) reported Net Income (Loss) Attributable to Noncontrolling Interest of -$250.00 thousand for the 3-month period ending 2025-01-31, per its 10-Q filed 2026-03-17.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2026-03-17
- Kestra Medical Technologies, Ltd. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-01-31 was -$250.00K.
- Kestra Medical Technologies, Ltd. net income (loss) attributable to noncontrolling interest for the quarter ending 2024-10-31 was -$253.00K.
- Kestra Medical Technologies, Ltd. net income (loss) attributable to noncontrolling interest for the quarter ending 2024-07-31 was -$439.00K.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 9 month |
|---|---|---|---|
| 2025-01-31 | -$250.00K 10-Q · filed 2026-03-17 | -$503.00K derived: sum of 2 quarters · filed 2026-03-17 | -$942.00K 10-Q · filed 2026-03-17 |
| 2024-10-31 | -$253.00K 10-Q · filed 2025-12-11 | -$692.00K 10-Q · filed 2025-12-11 | |
| 2024-07-31 | -$439.00K 10-Q · filed 2025-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |